| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 18.82B | 18.51B | 24.20B | 23.20B | 29.72B |
| Gross Profit | 10.03B | 9.82B | 9.65B | 9.82B | 11.64B |
| EBITDA | 9.75B | 9.28B | 8.38B | 10.12B | 10.93B |
| Net Income | 4.66B | 3.14B | 3.12B | 4.76B | 4.70B |
Balance Sheet | |||||
| Total Assets | 101.74B | 135.60B | 139.97B | 133.51B | 130.03B |
| Cash, Cash Equivalents and Short-Term Investments | 14.81B | 12.15B | 12.59B | 8.94B | 10.06B |
| Total Debt | 21.87B | 24.66B | 43.03B | 41.38B | 29.77B |
| Total Liabilities | 43.60B | 78.92B | 81.94B | 75.01B | 68.13B |
| Stockholders Equity | 42.92B | 41.66B | 41.80B | 43.33B | 46.21B |
Cash Flow | |||||
| Free Cash Flow | 7.25B | 10.10B | 9.93B | -5.58B | -9.34B |
| Operating Cash Flow | 8.12B | 11.09B | 10.71B | -2.68B | -5.37B |
| Investing Cash Flow | -1.13B | -4.17B | -2.50B | -5.79B | -5.85B |
| Financing Cash Flow | -8.27B | -4.68B | -5.30B | 7.97B | 10.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$567.41M | 5.37 | 3.64% | 6.03% | -7.06% | -38.60% | |
74 Outperform | HK$52.63B | 9.53 | 10.94% | 4.96% | 1.73% | 48.19% | |
70 Outperform | HK$1.68B | 4.09 | 2.82% | ― | 7.38% | 37.96% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | HK$8.03B | 4.22 | 6.61% | 5.22% | -9.02% | -39.00% | |
60 Neutral | HK$27.54B | 13.49 | 5.58% | 6.48% | -9.04% | -7.02% | |
55 Neutral | HK$699.80M | 3.87 | 3.62% | ― | -7.09% | -25.68% |